Skip to main
NHI

NHI Stock Forecast & Price Target

NHI Analyst Ratings

Based on 4 analyst ratings
Buy
Strong Buy 25%
Buy 50%
Hold 25%
Sell 0%
Strong Sell 0%

Bulls say

National Health Investors is a well-established healthcare REIT with a diverse portfolio of high-quality properties in the senior housing and medical facilities sector. It has a strong financial position with low leverage and a solid investment pipeline, which supports future growth potential. Its recent decision to sell its entire portfolio to National HealthCare Corporation (NHC), rather than just resetting rents, shows a long-term vision for organic growth and resolves any potential conflicts of interest. However, there are some risks, such as underperforming NHC rent reset or weaker deferred rent collection, that could affect the company's performance. Additionally, an increase in government reimbursement disruptions or higher national supply in the senior housing market could impact the company's stock performance and the achievement of its consensus price target. Overall, the stock is currently trading at a premium to its outlook, but with its strong portfolio and growth potential, it remains a solid investment for those with a longer-term perspective.

Bears say

National Health Investors is facing a negative outlook due to the sale of its portfolio to current lessee National HealthCare Corporation (NHC) for $560 million, resulting in a reduced FFO estimate for 2026 and 2027. While the decision to sell may improve long-term growth for the company, it also presents a potential loss of revenue and potential competition from a third party bidder. NHI has a high dependence on top operators which can add risk. Alternatively, NHI has high dependence on its top few operators, which can be good (given the struggles many weaker operators are having) or bad (even good operators can run intodifficulties).

NHI has been analyzed by 4 analysts, with a consensus rating of Buy. 25% of analysts recommend a Strong Buy, 50% recommend Buy, 25% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of National Health Investors and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About National Health Investors (NHI) Forecast

Analysts have given NHI a Buy based on their latest research and market trends.

According to 4 analysts, NHI has a Buy consensus rating as of May 5, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $88.75, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $88.75, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

National Health Investors (NHI)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.